Pier 88 Investment Partners’s Halozyme HALO Stock Holding History

Pier 88 Investment Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$665K	Sell	8,500 -10,500	-55%	-$716K	0.16%	43
2026 Q1	$1.23M	Sell	19,000 -280	-1%	-$19.7K	0.32%	41
2025 Q4	$1.3M	Sell	19,280 -780	-4%	-$52.5K	0.29%	42
2025 Q3	$1.47M	Buy	20,060 +9,540	+91%	+$634K	0.28%	41
2025 Q2	$547K	Buy	10,520 +2,570	+32%	+$146K	0.1%	83
2025 Q1	$507K	Buy	+7,950	New	+$462K	0.1%	85

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Pier 88 Investment Partners's HALO Position: Q2 2026 in Review

Pier 88 Investment Partners reduced its Halozyme (HALO) stake by 55% in Q2 2026, selling an estimated $716K and leaving 8,500 shares worth $665K. The position accounts for 0.16% of the portfolio, ranked #43.

Pier 88 Investment Partners first reported a position in HALO in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.47M in Q3 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Pier 88 Investment Partners held 8,500 shares of Halozyme worth $665K as of Q2 2026.
Pier 88 Investment Partners sold 10,500 Halozyme shares in Q2 2026, an estimated $716K.
Halozyme made up 0.16% of Pier 88 Investment Partners's portfolio in Q2 2026, its #43 holding.
Pier 88 Investment Partners first reported a position in Halozyme in Q1 2025 and has held it in 6 quarters since.
Pier 88 Investment Partners's Halozyme position peaked at $1.47M in Q3 2025.
674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Pier 88 Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.